US sets up $300 million database for Alzheimer’s disease research
Apr 05, 2023
In creating the database, the goal is to provide something that can “improve applicability and generalizability of findings.”
Jeanne Marrazzo will replace Fauci to lead National Institute of Allergy and Infectious Diseases
Aug 02, 2023
Marrazzo will start her new job in the fall.
FDA approves first interchangeable biosimilar for inflammatory diseases
Oct 19, 2021
Cyltezo is first interchangeable monoclonal antibody for rheumatoid, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis and chronic plaque psoriasis.
Medicare could negotiate drug prices under Democrat proposal
Nov 03, 2021
For the first time, the measure would enable the federal government to negotiate prices for medications covered by Medicare.
COVID-19 vaccine patent rules reconsidered by World Trade Organization
Jun 08, 2021
The idea is backed by more than 60 countries, including the United States.
Cranberry supplements may aid memory in older adults
May 24, 2022
Improvement in neural functioning also was seen during a 12-week intervention.
Gabapentinoids linked to increased risk for severe exacerbation in COPD
Jan 16, 2024
Compared with matched nonusers, gabapentinoid users have an increased risk across indications of epilepsy, neuropathic pain and other chronic pain.
FDA approves Capvaxive pneumococcal 21-valent conjugate vaccine
Jun 21, 2024
Merck says the vaccine covers serotypes responsible for approximately 84% of invasive pneumococcal disease in adults aged 50 or more years.
FDA to prioritize full approval for Pfizer COVID-19 vaccine
Jul 16, 2021
Full approval could help boost vaccination efforts in the United States.
FDA approves Izervay for geographic atrophy tied to age-related macular degeneration
Aug 09, 2023
Two trials show significant slowing of geographic atrophy progression at the 12-month primary end point.